491 related articles for article (PubMed ID: 33454768)
1. Early initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden.
Elenis E; Desroziers E; Persson S; Sundström Poromaa I; Campbell RE
Hum Reprod; 2021 Apr; 36(5):1427-1435. PubMed ID: 33454768
[TBL] [Abstract][Full Text] [Related]
2. Fecundity among women with polycystic ovary syndrome (PCOS)-a population-based study.
Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Sundström-Poromaa I
Hum Reprod; 2019 Oct; 34(10):2052-2060. PubMed ID: 31504532
[TBL] [Abstract][Full Text] [Related]
3. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
[TBL] [Abstract][Full Text] [Related]
4. Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study.
Chen X; Koivuaho E; Piltonen TT; Gissler M; Lavebratt C
Hum Reprod; 2021 Jul; 36(8):2345-2357. PubMed ID: 34046665
[TBL] [Abstract][Full Text] [Related]
5. Association of polycystic ovary syndrome or anovulatory infertility with offspring psychiatric and mild neurodevelopmental disorders: a Finnish population-based cohort study.
Chen X; Kong L; Piltonen TT; Gissler M; Lavebratt C
Hum Reprod; 2020 Oct; 35(10):2336-2347. PubMed ID: 32866965
[TBL] [Abstract][Full Text] [Related]
6. BMI in childhood and adolescence is associated with impaired reproductive function-a population-based cohort study from birth to age 50 years.
Laru J; Nedelec R; Koivuaho E; Ojaniemi M; Järvelin MR; Tapanainen JS; Franks S; Tolvanen M; Piltonen TT; Sebert S; Morin-Papunen L
Hum Reprod; 2021 Oct; 36(11):2948-2961. PubMed ID: 34364312
[TBL] [Abstract][Full Text] [Related]
7. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
Chen X; Gissler M; Lavebratt C
Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
[TBL] [Abstract][Full Text] [Related]
8. Effect of exposure to second-hand smoke from husbands on biochemical hyperandrogenism, metabolic syndrome and conception rates in women with polycystic ovary syndrome undergoing ovulation induction.
Li J; Wu Q; Wu XK; Zhou ZM; Fu P; Chen XH; Yan Y; Wang X; Yang ZW; Li WL; Stener-Victorin E; Legro RS; Ng EH; Zhang H; Mol BWJ; Wang CC;
Hum Reprod; 2018 Apr; 33(4):617-625. PubMed ID: 29471520
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts.
Farland LV; Stern JE; Liu CL; Cabral HJ; Coddington CC; Diop H; Dukhovny D; Hwang S; Missmer SA
Hum Reprod; 2022 Oct; 37(11):2690-2699. PubMed ID: 36149255
[TBL] [Abstract][Full Text] [Related]
10. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
12. Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact?
Mackens S; Pareyn S; Drakopoulos P; Deckers T; Mostinckx L; Blockeel C; Segers I; Verheyen G; Santos-Ribeiro S; Tournaye H; De Vos M
Hum Reprod; 2020 Oct; 35(10):2272-2279. PubMed ID: 32951028
[TBL] [Abstract][Full Text] [Related]
13. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome.
Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Poromaa IS
Fertil Steril; 2021 Sep; 116(3):862-871. PubMed ID: 34053678
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years.
Fernandez RC; Moore VM; Rumbold AR; Whitrow MJ; Avery JC; Davies MJ
Hum Reprod; 2021 Jul; 36(8):2275-2284. PubMed ID: 33963388
[TBL] [Abstract][Full Text] [Related]
15. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
[TBL] [Abstract][Full Text] [Related]
16. Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.
Haase CL; Varbo A; Laursen PN; Schnecke V; Balen AH
Hum Reprod; 2023 Mar; 38(3):471-481. PubMed ID: 36637246
[TBL] [Abstract][Full Text] [Related]
17. At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism.
Froment P; Plotton I; Giulivi C; Fabre S; Khoueiry R; Mourad NI; Horman S; Ramé C; Rouillon C; Grandhaye J; Bigot Y; Chevaleyre C; Le Guevel R; Mallegol P; Andriantsitohaina R; Guerif F; Tamburini J; Viollet B; Foretz M; Dupont J
Hum Reprod; 2022 May; 37(6):1207-1228. PubMed ID: 35459945
[TBL] [Abstract][Full Text] [Related]
18. Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome.
Santoro N; Eisenberg E; Trussell JC; Craig LB; Gracia C; Huang H; Alvero R; Casson P; Christman G; Coutifaris C; Diamond M; Jin S; Legro RS; Robinson RD; Schlaff WD; Zhang H;
Hum Reprod; 2016 Oct; 31(10):2268-79. PubMed ID: 27402910
[TBL] [Abstract][Full Text] [Related]
19. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.
Wei D; Shi Y; Li J; Wang Z; Zhang L; Sun Y; Zhou H; Xu Y; Wu C; Liu L; Wu Q; Zhuang L; Du Y; Li W; Zhang H; Legro RS; Chen ZJ
Hum Reprod; 2017 Feb; 32(2):354-361. PubMed ID: 27999118
[TBL] [Abstract][Full Text] [Related]
20. Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers.
Insenser M; Quintero A; de Lope S; Álvarez-Blasco F; Martínez-García MÁ; Luque-Ramírez M; Escobar-Morreale HF
Hum Reprod; 2023 May; 38(5):951-960. PubMed ID: 36931262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
